Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Minoxidil boosts hair growth by increasing cell production and survival.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Lowering testosterone speeds up wound healing in male mice.

Lower SHBG levels may increase the risk of PCOS.

Mouflon rams mature gradually with changes in body, horns, and hormones linked to age and seasons, reaching full sexual maturity well after puberty.

Minoxidil helps hair growth by activating the β-catenin pathway.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Early balding linked to higher heart disease risk.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.